Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
OMICS International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums
Migraine is a condition that causes episodes of headaches, with often other symptoms such as vomiting. There are four types of medicines that are generally used to treat migraine attacks: ordinary painkillers, anti-sickness medicines, anti-inflammatory painkillers, and triptans. Pain relievers are typically the first drugs recommended by doctors for migraine and headaches. Paracetamol or aspirin works well for many migraine attacks.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that ConferenceSeries hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
Anti-inflammatory painkillers probably work better than paracetamol to ease migraine .Other types such as diclofenac, naproxen, or tolfenamic acid need a prescription. Over-the-counter migraine medications used to address pain include analgesics, NSAIDS, and caffeine, including:
• Aspirin
• Naproxen (Naprosyn, Anaprox, Anaprox DS)
• Ibuprofen
• Acetaminophen (Tylenol)
List of Best International Conferences
List of related Companies
The migraine market is estimated to expand to $3.7 billion by 2023 at a compound annual growth rate (CAGR) of 3.6%. In the UK, there are an estimated 190,000 migraine attacks every day. The prevalence of migraine is estimated to be between 8.4-12.7% in Asia. In 1990 the Australian Bureau of Statistics reported the total cost of migraines to the Australian economy to be around $721 million per year, mostly due to loss of productivity at work and reduced occupational effectiveness.
This page will be updated regularly.
This page was last updated on November 22, 2024
